BOSTON (Reuters) - The crackdown on specialty pharmacies that compound drugs into customized doses on Monday yielded another recall after an inspection by the Food and Drug Administration. Pallimed Solutions Pharmacy, which specializes in treating erectile dysfunction, said it issued a voluntary recall of 16 sterile compound products, including injectable testosterone. Pallimed of Woburn, Massachusetts, also said it agreed to stop all sterile compounding activities. ... Get the complete story
No comments:
Post a Comment